Delivery Order SPE2DB20D2104-SPE2DB24FU78V

Award Date 6/20/24
Potential Completion Date 6/21/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,373.61 firm fixed-price delivery order is for the provision of LIVALO 1 MG TABLET 90S, a prescription medication. The contract has an ultimate completion date of December 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $64,538.17 Firm Fixed Price Delivery Order is for the supply of LIVALO 2 MG TABLET 90S, a prescription medication. The contract has a period of performance through September 26, 2023 and does not include any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award, valued at $1,763.44, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIVALO 2 MG TABLET 90S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of June 27, 2024 and is a Firm Fixed Price Delivery Order. The contract is not associated with a set-aside designation,...
This federal contract award, valued at $1,417.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of the prescription drug Livalo 1 mg tablets and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,711.72, is a delivery order for the supply of LIVALO 4 MG TABLET 90S, a prescription medication. The contract has an ultimate completion date of October 31, 2024 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any set-aside...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,146.26, is for the delivery of LIVALO 2 MG TABLET 90S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of November 15, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the delivery of LIVALO 1 MG TAB 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,919.62 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 23, 2024 and is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds...
This federal contract award, valued at $17,208.45, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of LIVALO 4 MG TABLET 90S, a pharmaceutical product, with a performance period ending on May 10, 2023. The contract has no set-aside...
This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of pharmaceutical products and medical supplies to support military and federal healthcare programs. The contract, valued at $1,190.91, is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA). It covers the procurement of a specific medication, LIVALO 2 MG TABLET 90S, with a period of performance through May 2, 2023. This award is not associated with a...
This contract award to AmerisourceBergen Drug Corp is a $14,381.89 firm-fixed-price delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The DLA IDC is a $999,999,999 contract vehicle that enables the federal government to efficiently procure a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. This specific...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FU78V
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,613.92 Firm Fixed Price Delivery Order covers the supply of LIVALO 4 MG TABLET 90S, a pharmaceutical product, with a period of performance through June 2024. The award is not designated as a set-aside contract.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/17/25, 10:12 AM